by Matthew Johnson | Mar 16, 2020 | PTAB News
By Matt Johnson – On March 13th, the PTAB issued the following notice: Until further notice, examiner and examining attorney interviews, Patent Trial and Appeal Board (PTAB) and Trademark Trial and Appeal Board (TTAB) oral hearings, and other similar in-person...
by Matthew Johnson | Mar 10, 2020 | PTAB News
On Monday, the PTAB Bar Association postponed its 2020 annual conference scheduled for this week, stating: The PTAB Bar Association has made the difficult decision to postpone this week’s conference in light of the increasing spread of COVID-19 and the uncertainty...
by Emily Tait | Feb 28, 2020 | Federal Circuit Appeal, PTAB News
By Emily Tait and Nate Andrews – The Federal Circuit continues to be flooded with petitions to revisit its panel decision in Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320, No. 2018-2140 (Fed. Cir. 2019). As previously discussed, all three parties in...
by Matthew Johnson | Feb 27, 2020 | PTAB News
By Matt Johnson – The institution rate for post-grant challenges in current FY 2020 (Oct. 1, 2019 through January 31, 2020) stands at 56% compared to 63% in the previous fiscal year. While a relatively small sample size (204 instituted, 161 denied), this is a number...
by Kenneth Luchesi | Feb 21, 2020 | PTAB News
By Kenny Luchesi – On remand from the Federal Circuit, the PTAB ruled that a patentee’s certificate of correction—issued after the Board invalidated the claims in a final written decision—could not be applied retroactively. After the IPR petition was filed, the...
by Matthew Johnson | Feb 13, 2020 | PTAB News
By Mike Lavine and Matt Johnson – On January 31, 2020, the Federal Circuit vacated and remanded a Patent Trial and Appeal Board (“PTAB”) final written decision in view of Arthrex, but did so reluctantly because it disagreed with the merits and questioned the...
